Dr. Lane received an M.S. and Ph.D. in Applied Science Engineering from the University of California at Davis in 1978. From 1978 until 1984 Dr. Lane was an experimental physicist in the Inertial Confinement Fusion (ICF) Program at Lawrence Livermore National Laboratory (LLNL), developing and fielding x-ray, neutron, and charged particle diagnostics for laser fusion implosion experiments. From 1984-1990 he was a Group Leader in the ICF program, responsible for 4-6 Ph.D. scientists and an engineering and technical staff, administering an annual budget of $3M. This group became the acknowledged international leader in nuclear diagnostics for laser fusion applications. In 1991, Dr Lane was a visiting scientist at the University of California, Berkeley, Nuclear Engineering Dept. where he designed novel gamma-ray spectrometers and dosimeters and taught graduate nuclear physics. Since 1992 Dr. Lane has been a senior scientist, Group Leader, and Associate Program Leader in the Medical Technology Division at LLNL.

Dr. Lane has been the principal investigator for the past 4 years of a DARPA funded program to develop collimator optics for proximity X-ray lithography and a NIST/NIH/industry funded program to develop a transdermal optical glucose sensor to treat diabetes.

Dr. Lane holds four patents, has over 40 publications and has received two R&D 100 Awards for one of the 100 most important inventions of the year. This year Dr. Lane received the 2001 Award for Excellence in Technology Transfer by the Federal Laboratory Consortium for Technology Transfer and, at a White House ceremony, the Department of Energy Bright Light Award for innovations that benefit the American public. Both of these awards were for work on optical glucose sensors for the treatment of diabetes.